Posner-Schlossman Syndrome
Conditions
Interventions
Research Group:sulodexide
Sponsors
The Eye of Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed with Posner-Schlossman Syndrome cannot control intraocular pressure and anterior chamber inflammation after using hormones (including some antiviral drugs) for 2 weeks, or whose intraocular pressure and inflammation rebound once hormone is stopped; Older than 18
Exclusion criteria
Exclusion criteria: 1. Allergies to sulodexide, heparin or heparin like drugs; 2. Patients with coagulation dysfunction or bleeding tendency; 3. Patients diagnosed with other eye diseases such as uveitis, keratopathy and fundus diseases , except for ametropia, cataract and glaucoma; 4. Patients with diseases requiring long-term sex hormone treatment and glucocorticoid treatment, such as primary aldosteronism, polycystic ovary syndrome and lupus erythematosus; patients taking spironolactone orally to control blood pressure; pregnant women and premenopausal women; 5. Patients who also participate in clinical trials of other drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraocular pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| anterior chamber inflammation; | — |
Countries
China
Contacts
Public ContactYuanbo Liang
The Eye of Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University
Outcome results
None listed